open access
Erratum to: “Pancreatic cancer and SBRT: A new potential option?” [Rep. Pract. Oncol. Radiother. 20 (2015) 377–384]
open access
Abstract
Local control remains a major issue for patients with unresectable, locally advanced pancreatic cancer (LAPC). The role of radiation therapy in the management of LAPC represents an area of some controversy. Stereotactic body radiotherapy is an emerging treatment option for LAPC as it can provide a therapeutic benefit with significant advantages for patients’ quality of life over standard conventional chemoradiation. The objective of this review is to present the rationale for stereotactic body radiotherapy in LAPC, as well as to discuss the potential limitations and caveats of the currently available studies.
Abstract
Local control remains a major issue for patients with unresectable, locally advanced pancreatic cancer (LAPC). The role of radiation therapy in the management of LAPC represents an area of some controversy. Stereotactic body radiotherapy is an emerging treatment option for LAPC as it can provide a therapeutic benefit with significant advantages for patients’ quality of life over standard conventional chemoradiation. The objective of this review is to present the rationale for stereotactic body radiotherapy in LAPC, as well as to discuss the potential limitations and caveats of the currently available studies.
Keywords
Pancreatic cancer; Stereotactic body radiotherapy; Local control
About this articleTitle
Erratum to: “Pancreatic cancer and SBRT: A new potential option?” [Rep. Pract. Oncol. Radiother. 20 (2015) 377–384]
Journal
Reports of Practical Oncology and Radiotherapy
Issue
Pages
491
Published online
2015-11-01
DOI
10.1016/j.rpor.2015.10.001
Bibliographic record
Rep Pract Oncol Radiother 2015;20(6):491.
Keywords
Pancreatic cancer
Stereotactic body radiotherapy
Local control
Authors
Carla Hajj
Karyn A. Goodman